ERBB2 and breast carcinoma: Triple-negative breast cancer (TNBC) accounts for 15–20 % of all breast cancer cases and is characterized by lack of estrogen- and progesterone receptor (ER, PR)-expression as well as lack of human epidermal growth factor receptor-2 (HER2) amplification [1, 2].